Frequency of glutamic acid decarboxylase autoantibodies in Mexican diabetic children

Revista de Investigacion Clinica

Volumn 52, Issue 4, 2000, Pages 427-431

  Mendoza Morfín, Fernando ^a,b   Curiel Pérez, María Oliva ^a   Cárdenas Tirado, Héctor ^a   Montero González, Patricia ^a   Gutiérrez Ávila, Cecilia ^a   Bravo Ríos, Luz Elena ^a   Cárdenas Cornejo, Imelda ^a   Normandía Almeida, María Asunción ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b NONE   (Mexico)

Author keywords

Anti GAD antibodies; Diabetes mellitus type 1

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE;

ADOLESCENT; ARTICLE; BLOOD; CHILD; ENZYMOLOGY; FEMALE; HUMAN; IMMUNOLOGY; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MEXICO; PRESCHOOL CHILD;

ADOLESCENT; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; INFANT; MALE; MEXICO;

EID: 0034221955     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Botazzo GF, Florin-Christensen A, Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974; 2: 1279-83.
2. Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK et al. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983; 222: 1337-9.
3. Bruining GJ, Molenaar JL, Grobee DE, Hofman A, Scheffer GJ, Bruining HA et al. Ten-year follow-up study of islet-cell antibodies and childhood diabetes mellitus. Lancet 1989; 1: 1100-3.
4. Bonifacio E, Bingley PJ, Shattock M, Dean BM, Dunger D, Gale EAM et al. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 1990; 335: 147-9.
5. Riley WJ, Maclaren NK, Krischer J, Spillar RP, Silverstein JH, Schatz DA et al. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 1990; 323: 1167-72.
6. Atkinson MA, Maclaren NK, Riley WJ, Winter WE, Fisk DD, Spillar RP. Are insulin autoantibodies markers for insulin-dependent diabetes mellitus? Diabetes 1986; 35: 894-8.
7. Verdi P, Dib SA, Tuttleman M, Connelly JE, Grinbergs M, Rabizadeh A et al. Competitive insulin autoantibody assay: prospective evaluation of subjects at high risk for development of type I diabetes mellitus. Diabetes 1987; 36: 1286-91.
8. Krischer JP, Schatz D, Riley WJ, Spillar RP, Silverstein JH, Schwartz S et al. Insulin and islet cell autoantibodies as time-dependent co-variates in the development of insulin-dependent diabetes: a prospective study in relatives. J Clin Endocrinol Metab 1993; 77: 743-9.
9. Ziegler R, Alper CA, Awdeh ZL, Castano L, Brink SJ, Soeldner JS et al. Specific association of HLA-DR4 with increased prevalence and level of insulin antibodies in first-degree relatives of patients with type I diabetes. Diabetes 1991; 40: 709-14.
10. Baekkeskov S, Nielsen JH, Marner B, Bilde T, Ludvigsson J, Lernmark A. Autoantibodies in newly diagnosed diabetic children with immunoprecipitate human pancreatic islet cell proteins. Nature 1982; 298: 167-9.
11. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M et al. Identification of the 64k autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990; 347: 151-6.
12. Solimena M, Folli F, Aparisi R, Pozza G, De Camilli P. Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiffman syndrome. N Engl J Med 1990; 322: 1555-60.
13. Rowley MJ, Mackay IR, Chen QY, Knowles WJ, Zimmet PZ. Antibodies to glutamic acid decarboxylase discriminate major types of diabetes mellitus. Diabetes 1992; 41: 548-51.
14. Atkinson MA, Maclaren NK, Scharp DW, Lacy PE, Riley WJ. 64000 Mr autoantibodies are predictive of insulin-dependent diabetes. Lancet 1990; 335: 1357-60.
15. Solimena M, Folli F, Denis-Donini S, Comi GC, Pozza G, De Camilli P et al. Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. N Engl J Med 1988; 318: 1012-20.
16. Li L, Hagopian WA, Brashear HR, Daniels T, Lernmark A. Identification of autoantibody epitopes of glutamic acid decarboxylase in stiff-man syndrome patients. J Immun 1994; 152: 930-4.
17. Sorenson RL, Garry DG, Brelje TC. Structural and functional considerations of GABA in islets of Langerhans β cells and nerves. Diabetes 1991; 40: 1365-74.
18. Rorsman P, Berggren PO, Bokvist K, Ericson H, Möhler H, Ostenson CG et al. Glucose-inhibition of glucagon secretion involves activation of GABA-receptor chloride channels. Nature 1989; 341: 233-6.
19. Christie MR, Pipeleers D, Lernamrk A, Baekkeskov S. Cellular specificity of the 64K islet antigen in type I diabetes. J Biol Chem 1990; 265: 376-81.
20. Hagopian WA, Michelsen B, Karlsen AE, Larsen F, Moody A, Grubin CE et al. Autoantibodies in IDDM primarily recognize the 65000-Mr rather than the 67000-Mr isoform of glutamic acid decarboxylase. Diabetes 1993; 42: 631-6.
21. 67 precede the onset of type I diabetes. Autoimmunity 1994; 19: 71-80.
22. 65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 1994; 43: 459-67.
23. Vandewalle CL, Falorni A, Svanholm S, Lenmark P, Pipeleers DG, Gorus FK et al. High diagnostic sensitivity of glutamate decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between age 20 and 40 years. J Clin Endocrinol Metab 1995; 80: 846-51.
24. The Expert Committee on the diagnosis and classification of diabetes mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-97.
25. Schmidli RS, Colman PG, Bonifacio E and Participating Laboratories. Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. The Second International GADAb workshop. Diabetes 1995; 44: 636-40.
26. Tuomi T, Zimmet P, Rowley MJ, Min HK, Vichayanrat A, Lee HK et al. Differing frequency of autoantibodies to glutamic acid decarboxylase among Koreans, Thais, and Australians with diabetes mellitus. Clin Immunol Immunopathol 1995; 74: 202-6.
27. Thai AC, Ng WY, Loke KY, Lee WRW, Lui KF, Cheah JS. Anti-GAD antibodies in Chinese patients with youth and adult-onset IDDM and NIDDM. Diabetologia 1997; 40: 1425-30.
28. 65 positivity and clinical characteristics. Clin Endocrinol 1997; 47: 455-61.
29. Chan JC, Yeung VT, Chow CC, Ko GT, Mackay IR, Rowley MJ et al. Pancreatic beta cell function and antibodies to glutamic acid decarboxylase (anti-GAD) in Chinese patients with clinical diagnosis of insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1996; 32: 27-34.
30. Tsuruoka A, Matsuba I, Toyota T, Isshiki G, Nagataki S, Ikeda Y. Antibodies to GAD in Japanese diabetic patients: a multicentric study. Diabetes Res Clin Pract 1995; 28: 191-9.
31. Yokota I, Matsuda J, Naito E, Ito M, Shima K, Kuroda Y. Comparison of GAD and ICA512/IA-2 antibodies at and after the onset of IDDM. Diabetes Care 1998; 21: 49-52.
32. Chen QY, Rowley MJ, Byrne GC, Jones TW, Tuomi T, Kjowles WJ et al. Antibodies to glutamic acid decarboxylase in Australian children with insulin-dependent diabetes mellitus and their first-degree relatives. Pediatr Res 1993; 34: 785-90.
33. Scheinin T, Minh NNT, Tuomi T, Miettinen A, Kontiainen S. Islet cell and glutamic acid decarboxylase antibodies and heat-shock protein 65 responses in children with newly diagnosed insulin-dependent diabetes mellitus. Immunol Lett 1996; 49: 123-6.
34. 65-and IA-2-autoantibodies with genetic risk markers in new-onset IDDM patients and their siblings. Diabetes Care 1997; 20: 1547-52.
35. 65 antibodies after clinical diagnosis of IDDM in young children. Diabetes Care 1997; 20: 642-4.
36. Hoeldtke RD, Bryner KD, Horvath GG, Byerly MR, Hobbs GR, Marcovina SM et al. Antibodies to GAD and glycemic control in recent-onset IDDM. Diabetes Care 1997; 20: 1900-3.